Analgesia Duration of Dexamethasone, Buprenorphine, or Clonidine With Ropivacaine for Interscalene Nerve Block

• Status: Completed
• Trial end date: 2017-03-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a prospective randomized controlled triple-masked study looking at the duration of nerve block analgesia when using the listed adjuvants (dexamethasone, buprenorphine and clonidine) plus ropivacaine versus plain ropivacaine alone.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Melinda Seering; University of Iowa
• Treatments: BB 1101; Buprenorphine; Clonidine; Dexamethasone; Dexamethasone 21-phosphate; Dexamethasone acetate; Ropivacaine

Criteria

Inclusion Criteria:

• Patients who have or are:

1. Orthopedics service patients having shoulder surgery

2. ASA(American Society of Anesthesiologists) class I, II, or III.

3. Patients at least 18 years old but less than 71 years old.

4. Patients giving informed consent.

5. Non-Emergency Surgery

Exclusion Criteria:

• Patients who have or are:

1. An inability to cooperate during the block placement.

2. Neuropathy of the planned extremity to block

3. Diabetes

4. Documented Kidney Disease

5. Documented Liver Disease

6. A lack of or inability to give informed consent.

7. Currently incarcerated.

8. Pregnant